Novo Nordisk has doubled down on position in the sickle cell disease (SCD) category with a $1.1 billion agreement to acquire Forma Therapeutics, and its therapeutic candidate etavopivat, in phase 2/3 ...
Novartis has said it is “disappointed” that the EMA’s Human Medicines Committee has recommended revoking the conditional EU approval for sickle cell disease (SCD) therapy Adakveo, and that it can no ...
Confused as to which scarecrow is the right one in Silent Hill f? Players can check out the guide below for the Field Puzzle solution.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback